These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15073406)

  • 1. Neuroprotective action of halogenated derivatives of L-phenylalanine.
    Kagiyama T; Glushakov AV; Sumners C; Roose B; Dennis DM; Phillips MI; Ozcan MS; Seubert CN; Martynyuk AE
    Stroke; 2004 May; 35(5):1192-6. PubMed ID: 15073406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of glutamatergic transmission by 3,5-dibromo-L-phenylalanine.
    Yarotskyy V; Glushakov AV; Sumners C; Gravenstein N; Dennis DM; Seubert CN; Martynyuk AE
    Mol Pharmacol; 2005 May; 67(5):1648-54. PubMed ID: 15687225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is pharmacological neuroprotection dependent on reduced glutamate release?
    Calabresi P; Picconi B; Saulle E; Centonze D; Hainsworth AH; Bernardi G
    Stroke; 2000 Mar; 31(3):766-72; discussion 773. PubMed ID: 10700517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders.
    Martynyuk AE; Seubert CN; Yarotskyy V; Glushakov AV; Gravenstein N; Sumners C; Dennis DM
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):261-70. PubMed ID: 18221208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glutamatergic synaptic transmission in the PKU brain.
    Martynyuk AE; Glushakov AV; Sumners C; Laipis PJ; Dennis DM; Seubert CN
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S34-42. PubMed ID: 16153867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses.
    Glushakov AV; Dennis DM; Sumners C; Seubert CN; Martynyuk AE
    J Neurosci Res; 2003 Apr; 72(1):116-24. PubMed ID: 12645085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
    Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M
    Neuropharmacology; 2016 Mar; 102():276-94. PubMed ID: 26647070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deficiency of β2-containing nicotinic receptors attenuates brain injury in ischemic stroke.
    Liu Q; Tang Z; Gan Y; Wu W; Kousari A; La Cava A; Shi FD
    Neuroscience; 2014 Jan; 256():170-7. PubMed ID: 24184117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
    Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
    Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
    Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
    Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a Synthetic Steroid 24-keto-cholest-5-en-3β, 19-diol as a Neuroprotectant.
    Yan M; Liu AL; Zhou SJ; Tang LP; Ou YQ; Yin W; Chen XY; Su XW; Qiu PX; Huang YJ; Zhang JX; Yan GM; Leng TD
    CNS Neurosci Ther; 2015 Jun; 21(6):486-95. PubMed ID: 25678034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
    Khansari PS; Halliwell RF
    Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective effect of a novel agent N2 on rat cerebral ischemia associated with the activation of PI3K/Akt signaling pathway.
    Huang J; Kodithuwakku ND; He W; Zhou Y; Fan W; Fang W; He G; Wu Q; Chu S; Li Y
    Neuropharmacology; 2015 Aug; 95():12-21. PubMed ID: 25725335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
    Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
    Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2.
    Li Z; Pang L; Fang F; Zhang G; Zhang J; Xie M; Wang L
    Brain Res; 2012 Apr; 1450():116-24. PubMed ID: 22410291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    Takahashi M; Kohara A; Shishikura J; Kawasaki-Yatsugi S; Ni JW; Yatsugi S; Sakamoto S; Okada M; Shimizu-Sasamata M; Yamaguchi T
    CNS Drug Rev; 2002; 8(4):337-52. PubMed ID: 12481190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of L-serine against temporary cerebral ischemia in rats.
    Wang GH; Jiang ZL; Chen ZQ; Li X; Peng LL
    J Neurosci Res; 2010 Jul; 88(9):2035-45. PubMed ID: 20186763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
    Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term changes in glutamatergic synaptic transmission in phenylketonuria.
    Glushakov AV; Glushakova O; Varshney M; Bajpai LK; Sumners C; Laipis PJ; Embury JE; Baker SP; Otero DH; Dennis DM; Seubert CN; Martynyuk AE
    Brain; 2005 Feb; 128(Pt 2):300-7. PubMed ID: 15634735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.